These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 492854)
1. [Tyrosine content in the blood as an index of the adequacy of glucocorticoid replacement therapy in congenital adrenal cortical dysfunction in children]. Rass IT; Kuznetsova ES; Zhukovskiĭ MA Pediatriia; 1979 Sep; (9):26-9. PubMed ID: 492854 [No Abstract] [Full Text] [Related]
2. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression. Keenan BS; McNeel R; Barrett GN; Holcombe JH; Kirkland RT; Clayton GW J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330 [No Abstract] [Full Text] [Related]
6. [Effect of glucocorticoids on potassium and sodium metabolism during the treatment of congenital dysfunction of the adrenal cortex]. Kozlov GI Probl Endokrinol (Mosk); 1973; 19(1):32-4. PubMed ID: 4698452 [No Abstract] [Full Text] [Related]
7. Osteocalcin in congenital adrenal hyperplasia. Lisá L; Neradilová M; Tomásová N; Soutorová M; Zimák J Bone; 1995 Jan; 16(1):57-9. PubMed ID: 7742084 [TBL] [Abstract][Full Text] [Related]
8. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated]. Loras B; Roux H; Audi-Parera L; David M; Bertrand J Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095 [No Abstract] [Full Text] [Related]
9. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Völkl TM; Simm D; Beier C; Dörr HG Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852 [TBL] [Abstract][Full Text] [Related]
10. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Webb EA; Krone N Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302 [TBL] [Abstract][Full Text] [Related]
11. Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia. Strott CA; Yoshimi T; Bardin CW; Lipsett MB J Clin Endocrinol Metab; 1968 Jul; 28(7):1085-8. PubMed ID: 5660261 [No Abstract] [Full Text] [Related]
12. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia]. Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256 [TBL] [Abstract][Full Text] [Related]
13. [A contribution to the therapy of the congenital adrenal hyperplasia (author's transl)]. Gleispach H Wien Klin Wochenschr; 1974 Sep; 86(17):508-11. PubMed ID: 4408420 [No Abstract] [Full Text] [Related]
14. Treatment-induced hypoandrogenism in childhood and puberty in females with virilizing (21-hydroxylase deficiency) congenital adrenal hyperplasia. New MI J Endocrinol; 1996 Sep; 150 Suppl():S31-2. PubMed ID: 8943784 [No Abstract] [Full Text] [Related]
15. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency. Sandrini R; Jospe N; Migeon CJ Acta Paediatr Suppl; 1993 Mar; 388():56-60; discussion 61. PubMed ID: 8329832 [TBL] [Abstract][Full Text] [Related]
16. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature]. Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842 [No Abstract] [Full Text] [Related]